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Abstract 
A pregnant woman (Gravida 2, Abortion 1, twin pregnancy with 
microinjection, Gestational Age: 23 weeks and 3 days) was referred to a tertiary 
referral hospital with complaints of fever, dry cough and dyspnea. She was 
admitted with a diagnosis of COVID-19. During her hospitalization, O2 
saturation progressively declined, which required acute respiratory care and 
support leading to intubation and mechanical ventilation. Gradual recovery 
occurred through treatment processes and finally the patient was extubated. 
However, there was another episode of respiratory failure leading to 
reintubation after 5 days. Meanwhile, serum liver enzymes increased 
significantly and leaded to intrauterine death of both fetus followed by a critical 
decline in cardiac output to less than 10% and cardiac arrest followed by 
unsuccessful resuscitation within hours. 
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The outbreaks of COVID-19 that emerged late 
2019 in China, resulted in a widespread ongoing 
transmission worldwide including Iran (1). Novel 
Coronavirus, rapidly develops into alveolar injury and 
progressive respiratory failure (2, 3).  
In the meantime, the health of pregnant women 
has become particularly important because maternal 
organs undergo many changes due to the effects of 
pregnancy. In china, all studies of COVID-19 pregnant 
women included single fetuses and no maternal deaths 
were reported by the virus (4, 5). A 38 years old woman 
with twin pregnancy was admitted to Imam Hossein 
(A.S.) hospital with complaints of fever, dry cough and 
dyspnea who were later diagnosed with COVID-19. 
This study indicates that multiple pregnancy mothers 
suffering from COVID-19 deemed to be poor 
prognosis cases. The study proposal was assessed and 
approved by Research Ethics Committee, Shahid 
Beheshti University of Medical Sciences, Tehran, Iran; 
coded: IR.SBMU.RETECH.REC.1399.021. 
Case Report 
A pregnant woman (Gravida 2, Abortion 1, twin 
pregnancy with microinjection, with Gestational Age 
of 23 weeks plus 3 days) was referred to Imam Hossein 
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(A.S.) Hospital, a tertiary university center in Tehran, 
Iran with complaints of fever, dry cough and dyspnea. 
She had no significant past medical disease. She had 
pulse rate of 92, respiratory rate of 21, with oral 
temperature of 37.5, O2 sat: 91% in room air and 94% 
with nasal flow O2 upon arrival. Obstetric ultrasound 
was performed and both fetuses were normal. 
Spiral lung and mediastinal CT scan without 
contrast injection was performed that showed no 
pulmonary nodules and pleural lesions. Pericardium 
was normal. The areas of patchy consolidation in both 
lungs, especially left lower lobe, with mild effusion on 
the left, were primarily suggestive of COVID-19 
pneumonia (Figure 1). Portable Chest X Ray was taken 
in which bilateral patchy airspace opacities were 
reported (Figure 2). 
 
Figure 1. Serial images of the Chest CT scanning (A to I). 
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The results of the initial tests were as follows: 
WBC: 6600/µL (Lymph: 9.5%), Hb: 86 g/L, PLT: 
191000/µL, Urea: 0.12 g/L, Cr: 0.008 g/L, CRP: 0.068 
g/L, ESR: 69 mm/Hr, PT: 11.4 seconds, TT: 24.6 
seconds, INR: 1.05, AST: 29 U/L, ALT: 11.3 U/L, 
ALKP: 131 U/L, Urine Analysis: Protein: negative, 
WBC: 1-2/High Power Field, RBC: 1-2/High Power 
Field, EPI Cell: 12-14/High Power Field, Venous 
Blood Gas Analysis: pH: 7.46, PvCO2: 30.8 torr 
HCO3-: 215 meq/L), with suspicion diagnosis 
of Coronavirus, we started treatment with oral 
Oseltamivir, Ceftriaxone, Hydroxychloroquine, 
Azithromycin, Lopinavir/ritonavir (Kaletra) and 
supplemental O2 therapy with mask. Nasopharyngeal 
secretion swab sampling was taken and sent for 
assessment of COVID-19 RT-PCR test, which was 
confirmed. 
After 24 hours, the patient’s condition worsened 
and O2 saturation dropped to 84%. The patient was 
transferred to the intensive care unit. After 36 hours in 
the ICU, due to progressive decline in respiratory 
status including increased respiratory rate to 40 
breaths/min and decreased O2 saturation to 65%, the 
patient was intubated using fentanyl and propofol 
injection and mechanical ventilation was started. Using 
synchronized intermittent mechanical ventilation 
(SIMV) with a frequency of 18/minute, PEEP=10 
mmHg and a tidal volume of 6 ml/Kg. Afterwards, the 
heart rate and O2sat recovered to 120 beats/min and 
82%, respectively. 
Then Cisatracurium and propofol infusion was 
started for the patient. Ventilator setting changed to 
controlled mechanical ventilation (CMV) with Tidal 
Volume=5 mL/Kg; Frequency=24/minute and positive 
end expiratory pressure (PEEP)=14 mmHg. However, 
two days after intubation, Cisatracurium infusion was 
tapered and then it was discontinued. Due to the 
deterioration of the patient's condition, a 
multidisciplinary team was formed with the 
participation of anesthesiologist, perinatologist, 
infectious medicine specialist, intensivist and forensic 
medicine specialist, which held a consultation meeting 
to decide, whether to terminate the pregnancy, which 
was contradicted. 
During the next days, hemoglobin concentration 
dropped to 69 g/L and the patient received one unit of 
isogroup packed blood cell. On the fourth day of 
admission, a 3 day-trial of intravenous 
immunoglobulin (IVIG) was started; 20 mg per day. 
Again, with a drop in hemoglobin, another unit of 
isogroup packed blood cell transfused. 
As the patient's lung, involvement worsened, 
with a high degree of suspicion towards hospital-
acquired pneumonia, a combination of intravenous 
standard dose of vancomycin and Meropenem were 
started. While azithromycin and ceftriaxone were 
tapered and then discontinued. After a week of 
hospitalization, the patient's general condition 
improved. 
After 12 days, with the improvement of O2 
saturation, the patient was weaned from the mechanical 
ventilator support and then alternately placed on 
spontaneous ventilation, which tolerated well. On the 
13th day of hospitalization the patient's sedation was 
totally discontinued, the patient was extubated, and 
high flow nasal cannula (HFNC) was used. 
Meanwhile, fetal heart rate of both fetuses were 
monitored regularly and continually to take the 
necessary measures would there be any change. 
Five days after extubation, the patient's 
condition deteriorated, leading again to intubation and 
mechanical ventilation. Bedside echocardiography and 
portable chest X ray demonstrated cardiomegaly and a 
modest decline in left ventricular ejection fraction 
(about 35%). Further imaging studies demonstrated an 
extensive recurring involvement of the lung tissues; 
while they had been in the course of delivery; the 
possibility of cardiogenic pulmonary edema was in the 
top of the differential diagnosis list. The lab tests 
 
Figure 2. Portable Anteroposterior Chest X Ray. 
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deteriorated; especially the results of hepatic tests and 
the coagulation profile. Two units of fresh frozen 
plasma were transfused. Besides, fetal heart rate 
monitoring aggravated with a very rapid decline 
towards asystole. Again, the multidisciplinary consult 
team was set up emergently within minutes and 
decided to terminate pregnancy with a high probability 
of intrauterine fetal death. In addition, the team 
strongly considered the possibility of myocardial 
injury and myocarditis due to COVID-19 infection. 
Meanwhile, episodes of refractory hypotension was 
observed, mandating norepinephrine infusion with 
moderate dose. Bedside monitoring of the cardiac 
function by transthoracic echocardiography 
demonstrated severe decline in cardiac function with 
an ejection fraction about 10-15%. Pregnancy was 
terminated through induction by intravenous infusion 
of misoprostol; however, the patient’s general and 
hemodynamic status aggravated and a sudden cardiac 
arrest led to unsuccessful cardiopulmonary bypass and 
death. 
Discussion 
Our experience with this patient demonstrated 
that twin pregnancy in patients with COVID-19 might 
end in a poor prognosis. It is also important to note that 
improvement in lung disease is not associated with 
relief of the risk for myocarditis or involvement of 
other organs; since the process of myocardial 
inflammation and injury due to COVID-19 is really a 
lethal one (6). Still the best recommendation for 
pregnant women is to consider strict quarantine, 
especially in women with multiple fetuses. 
 
Conclusion 
Pregnancy is undoubtedly a risk factor for 
immune system defense against COVID-19. There is 
robust evidence that these patients need much more 
sophisticated care. 
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